Moncton

Moncton has emerged as a dynamic hub within the Atlantic Canadian life sciences ecosystem, offering a strategic gateway for global pharmaceutical and biotechnology expansion.

The city is increasingly recognized for its robust healthcare innovation, driven by a collaborative network of academic research institutions and private-sector leaders.

At the heart of its value proposition is a specialized focus on precision medicine and clinical trials.

Moncton’s burgeoning medical device sector benefits from advanced manufacturing capabilities and a streamlined regulatory environment designed to accelerate market entry.

The region's commitment to bio-innovation is further bolstered by the Atlantic Cancer Research Institute (ACRI), a world-class facility pioneering breakthroughs in genomics and liquid biopsies.

Strategically located with multi-modal transport links, Moncton serves as a critical supply chain node for the distribution of biologics and essential medical supplies across North America.

Investors and entrepreneurs are drawn to the city's competitive operating costs and highly skilled workforce, cultivated through partnerships with the University of Moncton and local community colleges.

By fostering a culture of digital health transformation and R&D excellence, Moncton is redefining the future of patient care and life sciences commercialization.

This integrated approach ensures that the city remains a top-tier destination for companies seeking to scale their health technology solutions in a stable, innovation-led economy.